Last updated on December 2018

Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)


Brief description of study

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD

Detailed Study Description

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the correction of anemia and maintenance of Hb in subjects with NDD-CKD

Clinical Study Identifier: NCT02648347

Contact Investigators or Research Sites near you

Start Over

Akebia Therapeutics

Research Site
Hialeah, FL United States
  Connect »

Akebia Therapeutics

Research Site
Miami Springs, FL United States
2.54miles
  Connect »

Akebia Therapeutics

Research Site
Miami Lakes, FL United States
4.01miles
  Connect »

Akebia Therapeutics

Research Site
Doral, FL United States
5.48miles
  Connect »

Akebia Therapeutics

Research Site
Miami, FL United States
8.53miles
  Connect »

Akebia Therapeutics

Research Site
Sweetwater, FL United States
8.79miles
  Connect »

Akebia Therapeutics

Research Site
Coral Gables, FL United States
9.42miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.